Difficulty: Medium
Average Score: 94%
Practice
Wrong statement concerning pharmacokinetics of proton pump inhibitors
Correct answer
C
Rationale
The correct answer is C) Repeated administration decreases their bioavailability. This statement is accurate because with repeated dosing of proton pump inhibitors (PPIs), there can be induction of drug-metabolizing enzymes in the liver, leading to increased metabolism and decreased bioavailability of the drug over time.
Option A is incorrect because acid production in parietal cell canaliculi is not required for the activation of PPIs. These drugs work by irreversibly binding to the proton pump in the parietal cells, inhibiting acid secretion.
Option B is incorrect because PPIs are usually taken 30-60 minutes before a meal to optimize their effectiveness. This timing allows for adequate absorption and reaching the parietal cells before food-induced acid secretion occurs.
Option D is incorrect because food can actually enhance the bioavailability of PPIs. While some specific PPIs may recommend being taken on an empty stomach for optimal absorption, in general, food can improve the absorption of these drugs.
Educationally, understanding the pharmacokinetics of PPIs is crucial for healthcare professionals to ensure the appropriate dosing and timing of administration for maximum efficacy. Knowing how repeated dosing can affect bioavailability is essential for managing patients on long-term PPI therapy and avoiding potential treatment failures due to decreased drug levels in the body.
Option A is incorrect because acid production in parietal cell canaliculi is not required for the activation of PPIs. These drugs work by irreversibly binding to the proton pump in the parietal cells, inhibiting acid secretion.
Option B is incorrect because PPIs are usually taken 30-60 minutes before a meal to optimize their effectiveness. This timing allows for adequate absorption and reaching the parietal cells before food-induced acid secretion occurs.
Option D is incorrect because food can actually enhance the bioavailability of PPIs. While some specific PPIs may recommend being taken on an empty stomach for optimal absorption, in general, food can improve the absorption of these drugs.
Educationally, understanding the pharmacokinetics of PPIs is crucial for healthcare professionals to ensure the appropriate dosing and timing of administration for maximum efficacy. Knowing how repeated dosing can affect bioavailability is essential for managing patients on long-term PPI therapy and avoiding potential treatment failures due to decreased drug levels in the body.